To better understand the relationships between CCL23 and CXCL10 expression on patient survival, we performed an in silico assessment of patient outcomes based on the tumor expression levels using datasets hosted in the Cancer Genome Atlas (TCGA) database. This evidence concerns the gene CCL23 and neoplasm.